Narmada Gelatines reported a robust first quarter for FY27, with standalone revenue up 23% year-over-year. Standalone profit more than doubled, and consolidated profit also saw a significant increase, boosted by its associate company.
Narmada Gelatines Reports Strong Q1 FY27 Financial Results
Narmada Gelatines' standalone revenue reached ₹56.37 crore in Q1 FY27, a 23.16% increase from ₹45.77 crore in Q1 FY26.
Standalone profit for the period grew to ₹8.19 crore from ₹4.98 crore a year earlier.
Reader Takeaway: Strong revenue growth and significant profit increase driven by core operations and associate company contribution.
What just happened
Narmada Gelatines Ltd. announced its first-quarter financial results for the period ending June 30, 2026. The company posted standalone revenue from operations of ₹56.37 crore, marking a substantial 23.16% increase compared to ₹45.77 crore in the same quarter last fiscal year (Q1 FY26).
Profitability also saw a significant jump. Standalone profit for the quarter stood at ₹8.19 crore, a notable improvement from ₹4.98 crore in Q1 FY26. The consolidated profit for the period was reported at ₹9.33 crore. This increase in consolidated profit includes a ₹1.14 crore contribution from its associate company, India Gelatine Chemicals Limited.
The Board of Directors approved these unaudited financial results on August 12, 2026.
Why this matters
These results indicate a strong operational performance and a positive start to the financial year for Narmada Gelatines. The substantial year-over-year growth in both revenue and profit is a positive signal for investors. The contribution from the associate company further strengthens the consolidated financial health, suggesting effective group-level management.
The backstory
Narmada Gelatines operates in a single business segment focused on the manufacturing and sale of Gelatine and Dicalcium Phosphate (DCP). The company's performance is closely tied to the demand and pricing of these products in the domestic and international markets.
What changes now
With this strong quarterly performance, investors will be looking for continued momentum in the subsequent quarters. The company's ability to sustain this growth trajectory and manage its costs will be crucial. The market may react positively to these results, potentially influencing the stock's performance.
Risks to watch
While the current results are positive, potential risks could include volatility in raw material prices, changes in regulatory landscapes affecting the gelatin or DCP industry, and competitive pressures. Sustaining the growth from associate companies is also a factor.
Peer comparison
Specific peer comparison data is not provided in the filing. However, companies in the specialty chemicals and pharmaceutical ingredients sectors, which Narmada Gelatines' products cater to, often face similar market dynamics regarding input costs and demand cycles.
Context metrics (time-bound)
- Standalone Revenue (Q1 FY27): ₹56.37 crore
- Standalone Revenue (Q1 FY26): ₹45.77 crore
- Standalone Profit (Q1 FY27): ₹8.19 crore
- Standalone Profit (Q1 FY26): ₹4.98 crore
- Consolidated Profit (Q1 FY27): ₹9.33 crore
- Associate Contribution (Q1 FY27): ₹1.14 crore
- Earnings Per Share (EPS): ₹13.54
What to track next
Investors should track the company's performance in the upcoming quarters to see if this growth trend continues. Monitoring market demand for gelatin and DCP, as well as raw material costs, will be important indicators. The performance and contribution of India Gelatine Chemicals Limited will also be key.